ACTIVE_NOT_RECRUITING

Type 1 Diabetes Education and Support Study

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

Diabetes distress has been identified as one of the largest contributors to the racial disparity in glycemic control that disproportionately burdens Black patients ages 18-30 years with type 1 diabetes (T1D). In order to combat this issue, this study assesses the feasibility of the culturally tailored intervention T1DES and evaluates the effect of the T1DES intervention on diabetes outcomes in a pilot randomized clinical trial among Black young adults with T1D.

Official Title

Evaluating the Feasibility of Type 1 Diabetes Education and Support Intervention to Improve Diabetes Distress Among Black Young Adults

Quick Facts

Study Start:2023-04-15
Study Completion:2026-02-15
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:ACTIVE_NOT_RECRUITING

Study ID

NCT05735340

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years to 30 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT
Inclusion CriteriaExclusion Criteria
  1. * Kaiser Permanente Georgia Member
  2. * Aged 18 - 30 years
  3. * Confirmed diagnosis of Type 1 diabetes
  4. * Hemoglobin A1c \> 7.5 at time of enrollment
  5. * a cell phone able to send/receive text messages
  6. * Self-reported race of Black or African American
  7. * Ability to read in English and provide informed consent
  1. * Developmental delay or other cognitive impairment that would render the participant unable to provide informed consent
  2. * Subjects with visual impairment or have severe hearing or other physical disabilities that would be a barrier for participating in-group or web sessions
  3. * Diabetes complications that would preclude participation in the study

Contacts and Locations

Principal Investigator

Teaniese L Davis, PhD, MPH
PRINCIPAL_INVESTIGATOR
Principal Investigator

Study Locations (Sites)

Kaiser Permanente Georgia
Atlanta, Georgia, 30309
United States

Collaborators and Investigators

Sponsor: Kaiser Permanente

  • Teaniese L Davis, PhD, MPH, PRINCIPAL_INVESTIGATOR, Principal Investigator

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2023-04-15
Study Completion Date2026-02-15

Study Record Updates

Study Start Date2023-04-15
Study Completion Date2026-02-15

Terms related to this study

Keywords Provided by Researchers

  • diabetes
  • type 1

Additional Relevant MeSH Terms

  • Type1diabetes